Abstract
Derivation of human embryonic stem cell lines has been a remarkable scientific achievement during the last decade. Human embryonic stem cells are regarded as an unlimited cell source for replacement therapy in regenerative medicine. Clearly, the scientific community requires proper derivation, characterization, and registration with the purpose of making them available for research and future medical applications worldwide. In this paper, we report our derivation work as the Valencian Node of the Spanish Stem Cell Bank in the generation, characterization, and registration of VAL-3, -4, -5, -6M, -7, -8, and 9 (www.isciii/htdocs/terapia/terapia_bancocelular.jsp). The derivation process was performed on microbiologically tested and irradiated human foreskin fibroblasts and designed to minimize contact with xeno-components in knockout Dulbecco’s modified Eagle’s medium supplemented with knockout serum replacement and basic fibroblast growth factor. Fingerprinting of the cell lines was performed to allow their identification and traceability. All lines were expressed at the mRNA and specific protein markers for undifferentiation and were found to be negative for classical differentiation markers such as neurofilament heavy chain (ectoderm), renin (mesoderm), and amylase (endoderm). All lines displayed high levels of telomerase activity and were shown to successfully overcome cryopreservation and thawing. Finally, we demonstrated the potential to differentiate in vitro (embryoid body formation) and in vivo (teratoma formation) into cell types from all three germ layers. Teratoma derived from all human embryonic stem cell lines present similar morphological features except VAL-8 that display more aggressive tumor behavior with a larger proportion of solid tissues, as opposed to cyst formation in the other cell lines.
Similar content being viewed by others
References
Bjorklund A.; Lindvall O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3: 537–544; 2000.
Guhr A.; Kurtz A.; Friedgen K.; Löser P. Current state of human embryonic stem cell research: an overview of cell lines and their use in experimental work. Stem Cells 24: 2187–2191; 2006.
Hoffman L.; Carpenter M. Characterization and culture of human embryonic stem cells. Nat. Biotechnol. 23: 699–708; 2005.
Hovatta O.; Mikkola M.; Gertow K.; Strömberg A. M.; Inzunza J.; Hreinsson J.; Rozell B.; Blennow E.; Andäng M.; Ahrlund-Richter L. A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum. Reprod. 18: 1404–1409; 2003.
Hudson T. J.; Stein L. D.; Gerety S. S.; Ma J.; Castle A. B.; Silva J.; Slonim D. K.; Baptista R.; Kruglyak L.; Xu S. H.; Hu X.; Colbert A. M.; Rosenberg C.; Reeve-Daly M. P.; Rozen S.; Hui L.; Wu X.; Vestergaard C.; Wilson K. M.; Bae J. S.; Maitra S.; Ganiatsas S.; Evans C. A.; DeAngelis M. M.; Ingalls K. A.; Nahf R. W.; Horton Jr. L. T.; Anderson M. O.; Collymore A. J.; Ye W.; Kouyoumjian V.; Zemsteva I. S.; Tam J.; Devine R.; Courtney D. F.; Renaud M. T.; Nguyen H.; O’Connor T. J.; Fizames C.; Fauré S.; Gyapay G.; Dib C.; Morissette J.; Orlin J. B.; Birren B. W.; Goodman N.; Weissenbach J.; Hawkins T. L.; Foote S.; Page D. C.; Lander E. S. An STS-based map of the human genome. Science 270: 1945–1954; 1995.
Itskovitz-Eldor J.; Schuldiner M.; Karsenti D.; Eden A.; Yanuka O.; Amit M.; Soreq H.; Benvenisty N. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 6: 88–95; 2000.
Kimpton C.; Walton A.; Gill P. A further tetranucleotide repeat polymorphism in the vWF gene. Hum. Mol. Genet. 1: 287; 1981.
Li H.; Schmidt L.; Wei M. H.; Hustad T.; Lerman M. I.; Zbar B.; Tory K. Three tetranucleotide polymorphisms for loci: D3S1352; D3S1358; D3S1359. Hum. Mol. Genet. 2: 1327; 1993.
Martin M.; Muotri A.; Gage F.; Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11: 228–232; 2005.
Mills K.; Even D.; Murray J. Tetranucleotide repeat polymorphism at the human alpha fibrinogen locus (FGA). Hum. Mol. Genet. 1: 779; 1992.
Oldroyd N.; Urquhart A.; Kimpton C.; Millican E. S.; Watson S. K.; Downes T.; Gill P. D. A highly discriminating octoplex short tandem repeat polymerase chain reaction system suitable for human individual identification. Electrophoresis 16: 334–337; 1995.
Pickering S.; Braude P.; Patel M.; Burns C. J.; Trussler J.; Bolton V.; Minger S. Preimplantation genetic diagnosis as a novel source of embryos for stem cell research. Reprod. Biomed. Online 7: 353–364; 2003.
Reubinoff B.; Pera M.; Fong C.; Trounson A.; Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18: 399–404; 2000.
Rodriguez C.; Galan A.; Valvuena D.; Simon C. Derivation of clinical-grade human embryonic stem cells. Reprod. Biomed. Online 12: 112–118; 2006.
Sharma V.; Litt M. Tetranucleotide repeat polymorphism at the D21S11 locus. Hum. Mol. Genet. 1: 67; 1992.
Simon C.; Escobedo C.; Valbuena D.; Genbacev O.; Galan A.; Krtolica A.; Asensi A.; Sánchez E.; Esplugues J.; Fisher S.; Pellicer A. First derivation in Spain of human embryonic stem cell lines: use of long-term cryopreserved embryos and animal-free conditions. Fertil. Steril. 83: 246–249; 2005.
Sullivan K.; Mannucci A.; Kimpton C.; Gill P. A rapid and quantitative DNA sex test: fluorescence-based PCR analysis of X-Y homologous gene amelogenin. Biotechniques 15: 636–641; 1993.
The international stem cell initiative. Characteristics of human embryonic stem cell lines: results from the international Stem Cell Initiative. Nat. Biotechnol. 25: 803–816; 2007.
Thomson J.; Itskovitz-Eldor J.; Shapiro S.; Waknitz M.; Swiergiel J.; Marshall V.; Jones J. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147; 1998.
Urquhart A.; Oldrovd N.; Kimpton C. Highly discriminating heptaplex short tandem repeat PCR system for forensic identification. Biotechniques 18(116–118): 120–121; 1995.
Valbuena D.; Galán A.; Sánchez E.; Poo M. E.; Gómez E.; Sánchez-Luengo S.; Melguizo D.; García A.; Ruiz V.; Moreno R.; Pellicer A.; Simón C. Derivation and characterization of three new Spanish human embryonic stem cell lines (VAL -3–4 -5) on human feeder and in serum-free conditions. Reprod. Biomed. Online 13: 875–886; 2006.
Valbuena D.; Sánchez-Luengo S.; Galán A.; Sánchez E.; Gómez E.; Poo M. E.; Ruiz V.; Genbacev O.; Krtolica A.; Pellicer A.; Moreno R.; Simón C. Efficient method for slow cryopreservation of human embryonic stem cells in xeno-free conditions. Reprod. Biomed. Online 17: 127–135; 2008.
Acknowledgments
This work was founded by the Regenerative Medicine Program, Conselleria de Sanidad, Generalitat Valenciana, Institute of Health Carlos III (Ministry of Health), Spanish Government, PI Carlos Simon and FIS (PI08-1134) PI Diana Valbuena.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: J. Denry Sato
Rights and permissions
About this article
Cite this article
Aguilar-Gallardo, C., Poo, M., Gomez, E. et al. Derivation, characterization, differentiation, and registration of seven human embryonic stem cell lines (VAL-3, -4, -5, -6M, -7, -8, and -9) on human feeder. In Vitro Cell.Dev.Biol.-Animal 46, 317–326 (2010). https://doi.org/10.1007/s11626-010-9285-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-010-9285-3